How to Read and Evaluate an Exosome Certificate of Analysis (COA)

How to Read and Evaluate an Exosome Certificate of Analysis (COA)

Stem Nova Network
Quality Documentation · For Licensed Practitioners
By Stem Nova Network | November 2026 | 10 min read | For licensed medical professionals only

A Certificate of Analysis is the single most important document your supplier hands you — and most practitioners never read it. That is a problem. The COA is where manufacturing claims either hold up or fall apart. It is the document that tells you what is actually in the vial, how it was tested, and whether anyone independent verified the results.

If you are integrating topical cosmetic exosome biologics into your practice, learning to read a COA is not optional. It is the difference between informed purchasing and blind trust.

This guide walks through each section of a typical exosome COA, explains what the numbers mean, and flags the red lines that should prompt a second conversation with your supplier.

Key takeaway: A complete exosome COA should include NTA-verified particle concentration, particle size distribution, sterility testing, endotoxin testing, and mycoplasma testing — all tied to a specific lot number. If any of these are missing, or the COA is not lot-specific, that is a documentation gap worth investigating before committing to a supplier.

What Is a Certificate of Analysis?

A COA is a quality document issued by a testing laboratory that reports the results of specific assays performed on a defined product lot. Every lot of exosome biologics should ship with a COA that matches its lot number. If a supplier cannot produce a lot-specific COA on request, that is the first red flag.

In the biologics space, COAs serve a narrow but critical function: they document the measurable characteristics of the product at the time of release. They do not make efficacy claims. They do not substitute for clinical judgment. They tell you what the testing found — nothing more.

The Six Core Sections of an Exosome COA

1. Product Identification and Lot Number

Every COA should open with basic identifiers: the product name, lot or batch number, manufacturing date, and expiration date. The lot number on the COA must match the lot number on the vial. If it does not, the COA is meaningless for that unit.

What to verify

✓
Lot number matches the vial label exactly
✓
Manufacturing and expiration dates are present
✓
Product name and volume match what was ordered

2. Particle Concentration (NTA)

Particle concentration is measured by Nanoparticle Tracking Analysis (NTA) and reported as particles per milliliter (P/mL). This is the headline number on most exosome COAs — for example, a reading of 6.0 × 10¹⁰ P/mL tells you there are approximately 60 billion particles per milliliter in that lot.

NTA works by tracking the Brownian motion of individual particles suspended in liquid using a laser and camera system. It counts and sizes particles one at a time, which makes it more precise for heterogeneous biological samples than bulk-averaging methods.

What to look for

✓
The specific NTA instrument should be named (e.g., NanoSight)
✓
Concentration should be reported with units (P/mL)
✓
The measurement should be lot-specific, not a generic range

A COA that reports concentration without naming the instrument or methodology should raise questions. “Particle count” without context does not tell you how the measurement was taken or how reliable it is.

3. Particle Size Distribution

NTA also reports mean particle size in nanometers (nm). Exosome-range particles typically fall between 30 nm and 150 nm, though a broader size distribution is not unusual in minimally processed biological products.

A typical readout might report a mean size of 134.0 nm. This tells you the average particle diameter across the sample. Some COAs will also include a mode (most common size) and a size distribution graph showing the spread.

What matters here is consistency. If your supplier reports a mean particle size of 130 nm on one lot and 400 nm on the next, the product characteristics are varying significantly between batches.

4. Sterility Testing

Sterility testing confirms that the product is free of microbial contamination. The expected result on a COA is “No Growth” after a defined incubation period (typically 14 days per USP <71> standards).

This is a pass-or-fail line. Any result other than “No Growth” means the lot did not meet sterility requirements.

What to verify

✓
Result states “No Growth” (not “Pending” or “In Progress”)
✓
The test method is referenced (USP <71> is the standard)
✓
Incubation period is documented

5. Endotoxin Testing

Endotoxin testing measures bacterial lipopolysaccharide contamination, reported in Endotoxin Units per milliliter (EU/mL). The lower the number, the better. A result of <0.005 EU/mL, for example, indicates endotoxin levels well below the standard thresholds established by USP <85> (the Bacterial Endotoxins Test).

This test is performed using the Limulus Amebocyte Lysate (LAL) assay or a recombinant alternative. It is distinct from sterility testing — a product can pass sterility and still carry endotoxin if the manufacturing process did not adequately control for it.

6. Mycoplasma Testing

Mycoplasma contamination is a persistent concern in cell-culture-derived biologics because mycoplasma can survive standard sterilization. The expected COA result is “Negative” or “Not Detected.”

Mycoplasma testing is typically performed via PCR (polymerase chain reaction), which is more sensitive than traditional culture methods.

A COA that omits mycoplasma testing entirely is incomplete. If your supplier does not test for mycoplasma, ask why.

Beyond the Core Six: Additional Assays Worth Asking About

Some COAs include additional characterization data beyond the six sections above. These are not always present, but when they are, they provide a more complete picture:

Protein Concentration (Bradford Assay) — Reported in micrograms per milliliter (μg/mL), protein concentration reflects the total protein content associated with the exosome preparation. For example, a Bradford assay result of 4,824.6 μg/mL provides a secondary measure of product content alongside particle count. This is not a direct measure of exosome purity, but it adds another data point for lot-to-lot comparison.

Appearance and pH — Basic physical characterization. The product should be described (e.g., clear to slightly opalescent liquid) and pH should fall within the documented specification range.

Cell Marker Panels — Some COAs for cell-derived products may include flow cytometry data for surface markers. These results describe the source cell characterization and are more commonly found on COAs for tissue products such as hUCT-MSC rather than on exosome COAs.

Single-Lab vs. Dual-Lab COA Verification

Here is a question most practitioners never think to ask: who performed the testing?

A single-lab COA means the manufacturer tested its own product and reported its own results. That is standard in many industries, but it is also a conflict of interest. The entity selling the product is the same entity verifying its quality.

Dual-lab COA verification adds an independent layer. The product is tested by the manufacturing facility and then independently verified by a second, separate laboratory. When both sets of results align, you have external confirmation that the numbers are accurate.

This is the same principle behind independent financial audits. A company’s internal accounting may be perfectly accurate, but external verification removes the question.

Factor Single-Lab COA Dual-Lab COA
Who tests Manufacturer only Manufacturer + independent lab
Independence Self-reported results Externally verified results
Conflict of interest Present — seller verifies own product Mitigated — third party confirms
Documentation depth Single data set Two independent data sets
Industry comparison Standard practice Comparable to independent financial audit

When evaluating a supplier, ask:

  • Is your COA tested by a single lab or verified by two independent labs?
  • Can you provide documentation from both testing facilities?
  • Are both labs operating under cGTP-compliant (21 CFR Part 1271) conditions?

Red Flags on an Exosome COA

Documentation red flags: Not every COA tells the full story. The following warning signs should prompt further questions before committing to a wholesale relationship.

Generic or range-based results — A COA should report specific, lot-level measurements. If particle count is listed as “50–100 billion” rather than a precise NTA reading, the data may not be lot-specific.

Missing test sections — A complete exosome COA should include, at minimum: NTA particle concentration, particle size, sterility, endotoxin, and mycoplasma. If any of these are absent, ask for clarification.

No lot number match — The COA lot number must correspond to the product lot number on the vial. A supplier who provides a “representative” COA rather than a lot-specific one is not providing adequate documentation.

No instrument or method references — Professional COAs cite the instruments and standards used (NanoSight for NTA, USP <71> for sterility, USP <85> for endotoxin, PCR for mycoplasma). A COA that omits these references provides results without accountability.

Results listed as “Pending” — If testing was not complete at the time of release, the COA is incomplete. Product should not ship ahead of final test results.

Questions to Ask Your Supplier

Before placing a wholesale order, these questions will tell you whether a supplier’s documentation meets a professional standard:

  1. Can you provide a lot-specific COA for every lot I purchase?
  2. Is particle concentration measured by NTA on a named instrument?
  3. Is your COA single-lab or dual-lab verified?
  4. What are your endotoxin specifications, and what method do you use?
  5. Do you test every lot for mycoplasma?
  6. Is your facility FDA-registered and cGTP-compliant (21 CFR Part 1271)?
  7. Can I access COAs digitally before the product ships?

A supplier who can answer all seven without hesitation is operating at a professional standard. Gaps in any of these areas are worth exploring further before committing to a wholesale relationship.

How to Use COA Data in Practice

COA documentation serves your practice in three ways:

Informed purchasing — Reviewing COAs across lots and across suppliers lets you compare product consistency, testing rigor, and documentation quality before committing purchase volume.

Compliance documentation — Maintaining COAs on file for every lot you purchase demonstrates due diligence. If a regulatory question arises, lot-level documentation shows that you sourced characterized products from a facility operating under appropriate manufacturing standards.

Supplier accountability — When you routinely request and review COAs, you signal to your supply chain that documentation quality matters. This creates a feedback loop that benefits the entire biologics ecosystem.

The Bottom Line

A COA is not a marketing document. It is a quality record. Learning to read one — and knowing what questions to ask when something is missing — is one of the most practical steps a licensed professional can take when integrating biologics into practice.

The numbers on the COA do not tell you everything. But they tell you whether the basic quality controls are in place, whether testing was rigorous, and whether your supplier is willing to stand behind their product with verifiable data.

At Stem Nova Network, every lot ships with a dual-lab COA verified by two independent laboratories. Our COAs include NTA-verified particle characterization, sterility, endotoxin, mycoplasma, and protein content data — because documentation should answer questions, not create them.

See your lot-specific COA documentation before you order.

Stem Nova Network is an FDA-Registered Tissue Establishment, cGTP-compliant under 21 CFR Part 1271. Every lot ships with a dual-lab COA verified by two independent laboratories.

Enroll Your Practice Contact Our Team

Frequently Asked Questions

What is a Certificate of Analysis (COA)?
A COA is a quality document issued by a testing laboratory that reports the results of specific assays performed on a defined product lot. It documents the measurable characteristics of the product at the time of release — including particle concentration, size distribution, sterility, endotoxin, and mycoplasma testing. It does not make efficacy claims or substitute for clinical judgment.
What is dual-lab COA verification?
Dual-lab COA verification means the product is tested by the manufacturing facility and then independently verified by a second, separate laboratory. When both sets of results align, you have external confirmation that the numbers are accurate. This is the same principle behind independent financial audits — external verification removes the conflict of interest inherent in self-reported quality data.
What should a complete exosome COA include?
A complete exosome COA should include, at minimum: NTA-verified particle concentration (reported as P/mL with a named instrument), particle size distribution (mean size in nm), sterility testing (USP <71>), endotoxin testing (USP <85>), and mycoplasma testing (PCR method). Additional assays such as protein concentration (Bradford assay), appearance and pH, and cell marker panels provide a more complete picture when available.
What NTA instrument should be listed on the COA?
Professional COAs should name the specific NTA platform used for particle characterization — for example, NanoSight. Naming the instrument tells the reader which platform generated the data, which affects how the numbers should be interpreted. A COA that reports particle data without naming the instrument or methodology is considered incomplete documentation.
How do I verify my COA lot number matches my vial?
Check the lot or batch number printed on the vial label and compare it directly to the lot number listed on the COA document. They must match exactly. If a supplier provides a “representative” COA rather than a lot-specific one, the documentation does not correspond to the specific product you received. Every vial should have a COA that matches its individual lot number.
Can I access COAs before product ships?
With Stem Nova Network, enrolled practices can access lot-specific COA documentation digitally through the wholesale portal. COAs are available for review before product ships, and every shipment includes the corresponding dual-lab COA verified by two independent laboratories. This is one of the seven questions worth asking any prospective supplier.
Regulatory Notice: This article is for informational purposes only and is intended for licensed medical professionals. Stem Nova Network biologics are supplied for licensed professional use only. Exosome biologic products are intended for topical professional use only and are not FDA-approved drugs. There are currently no FDA-approved exosome products in the United States. All clinical decisions are the sole responsibility of the licensed practitioner. Patients should consult their primary care physician.